In patients with advanced pancreatic cancer, highly glycosylated forms of prominin-1 were found to be more strongly expressed in EVs collected from malignant ascites compared to those derived from non-malignant ascites from liver cirrhosis or patients with gastric cancer [507]. The gene discussed is PROM1; the disease is pancreatic neoplasm.